.svg){kind=small}
Jan-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the dynamic cannabis market, Jumbodose has shown a consistent presence in the Tincture & Sublingual category within New York. Over the months from October 2024 to January 2025, Jumbodose maintained a steady third-place ranking, indicating a strong foothold in this specific category. Despite fluctuations in sales figures, the brand's ability to hold its position suggests a loyal customer base and effective product offerings. This stability in ranking, even with varying sales, highlights the brand's resilience and potential market strategies that could be maintaining its competitive edge.
However, it's important to note that Jumbodose's presence outside of the Tincture & Sublingual category in New York is not visible in the top 30 rankings for other categories, which could be a point of concern or a strategic focus on a niche market. The absence of rankings in other states or provinces suggests that Jumbodose might be concentrating its efforts primarily in New York, or it may indicate opportunities for expansion. The brand's strategy and market performance in New York could serve as a model for potential growth in other regions, but the lack of a broader geographic footprint might also limit its overall market influence.
Competitive Landscape
In the New York Tincture & Sublingual category, Jumbodose consistently held the third rank from October 2024 through January 2025, indicating a stable position in the market despite fluctuations in sales. While maintaining its rank, Jumbodose experienced a notable decline in sales from $230,904 in October 2024 to $122,087 in January 2025, suggesting potential challenges in maintaining consumer interest or market share. In contrast, Ayrloom and Head & Heal consistently occupied the first and second ranks, respectively, with both brands showing strong sales growth over the same period. Ayrloom's sales surged significantly, reaching $481,429 in January 2025, while Head & Heal also saw an increase to $408,989. The consistent top rankings and sales growth of these competitors highlight the competitive pressure Jumbodose faces, emphasizing the need for strategic initiatives to bolster its market position and sales performance.
Notable Products
In January 2025, Jumbodose's top-performing product was the Hybrid Mega Tincture (1000mg THC, 30ml, 1oz), maintaining its position as the leading product for four consecutive months, with sales reaching 533 units. The CBD/THC 5:1 Chill Tincture (1500mg CBD, 300mg THC, 30ml) climbed to the second spot, showing consistency as it held the fourth position from October to December 2024. The CBG/THC 5:1 Focus Tincture (1500mg CBG, 300mg THC, 30ml) remained steady at third place, slightly dropping from its second-place ranking in November 2024. The CBN/THC 5:1 Doze Tincture (1500mg CBN, 300mg THC, 30ml) slipped to fourth place, having ranked second in October and December 2024. Lastly, the Rosin Drops Hash Tincture (300mg THC, 30ml) consistently held the fifth position throughout the observed months.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
